Pharmacotherapy of Thyroid Medications Exam 1 Flashcards
clinical presentation of hyperthyroidism
- Nervousness
- Sweating
- Palpitations
- Fatigue / weakness
- Oligomenorrhea
- Loss of libido
- Emotional lability
What are signs / symptoms upon a physical exam that could denote hyperthyroidism?
- high blood pressure
- high heart rate
- thyroid palpitation and auscultation to determine size, nodularity and vascularity
- eye exam
What are lab abnormalities with hyperthyroidism?
- Low TSH
- High TT4
- High FT4
- High TT3
What are additional tests that can be done to confirm hyperthyroidism?
- thyrotropin receptor antibodies
- radioactive iodine uptake
- measurement of thyroidal blood flow on ultrasonagraphy
What are the treatment options for hyperthyroidism?
- Thioamides
- Potassium Iodide
- Beta Blockers
- Radioactive Iodine (RAI)
- Surgery (Thyroidectomy)
Thioamides indication
- mild hyperthyroidism
- preoperative preparation for thyroidectomy
- pretreatment for RAI in elderly or patients with cardiac disease
- elderly
- thyroid storm
- Grave’s disease
- pregnancy
Thioamides MOA
Inhibits synthesis of thyroid hormones by inhibiting coupling of MIT and DIT and formation of T3 and T4; propylthiouracil also inhibits the peripheral conversion of T4 to T3
Thioamides monitoring
- complete blood count (CBC) to evaluate neutropenia and
- liver function test (LFT) due to hepatotoxic risk
- T3, T4, and TSH 4 weeks after initiation and at 8 week intervals until euthyroid levels achieved, then every 6 months
Thioamides adverse effects
- rash
- arthralgias
- drowsiness
- flulike symptoms
- abdominal pain
- GI intolerance in 4-5% of
patients - edema
- headache
Thioamides severe adverse effects
- Agranulocytosis
- Hepatotoxicity
- Fever
- Pneumonitis
- DO NOT rechallenge the patient if any of this occurs
Thioamides severe adverse effects: Agranulocytosis
- fever, malaise, gingivitis, oropharyngeal infection, and granulocyte count <250mm3
- more common in patients >40 yoa who are receiving MMI doses >40mg/day or PTU doses >400mg/day
- typically occurs during 1st three months of therapy
- after stopping therapy, improvement seen withing a few days to a few weeks
Thioamides severe adverse effects: Hepatotoxicity
Typically occurs during 1st three months of therapy
Thioamides advantages
- Noninvasive
- lower initial cost (~$45-90)
- low risk of permanent hypothyroidism and lifelong treatment
- avoidance of surgery and radioactivity exposure
Thioamides disadvantages
- Low cure rate
- adverse drug reactions
- drug adherence
Thioamides pearls
- PTU is preferred in 1st trimester of pregnancy or lactation
- PTU drug of choice in thyroid storm because of the earlier onset of action
- Effect can be delayed by weeks since is blocks production of new hormones
- Clinical improvement usually seen within 3 months
- Discontinue therapy after 12-18 months if values normalize
Potassium Iodide indication
- Preparation for surgery
- quickly attain euthyroid state in patients severely thyrotoxic with cardiac compromise
- to inhibit thyroid hormone release following RAI
Potassium Iodide MOA
Inhibits secretion of thyroid hormone
Potassium Iodide monitoring
Thyroid function (T3, T4, TSH) 6 weeks after initiation and every 8 weeks until euthyroid and then annually
Potassium Iodide adverse effects
- Hypersensitivity reactions
- salivary gland swelling
- “iodism” (metallic taste, burning mouth and throat, sore teeth and gums)
- stomach upset
- diarrhea
- gynecomastia
Potassium Iodide contraindications
- Hypersensitivity
- nodular thyroid condition with heart disease
Potassium Iodide advantages
Rapid and effective in severe thyrotoxicosis and rapid onset (24-48 hours)
Potassium Iodide disadvantages
Maximal effect is only sustained for 10-15 days
Beta Blockers indication
- Adjunct therapy for relief of symptoms of palpitations, anxiety, tremor and heat tolerance
- adjunct therapy for Grave’s disease, toxic nodules, preparation for surgery
- used in thyroid storm
Beta Blockers MOA
Inhibits beta adrenergic receptors and partially inhibits peripheral conversion of T4 to T3 at high doses